Frampton CM - Search Results

1

Prevalence of gallbladder disease in diabetes mellitus.

Chapman BA, Wilson IR, Frampton CM, Chisholm RJ, Stewart NR, Eagar GM, Allan RB. Chapman BA, et al. Among authors: frampton cm. Dig Dis Sci. 1996 Nov;41(11):2222-8. doi: 10.1007/BF02071404. Dig Dis Sci. 1996. PMID: 8943976 Clinical Trial.

2

Comparison of endoscopic forceps biopsies and capsule biopsies in determining disaccharidase activity in the duodenum.

Wilson IR, Oxner RB, Frampton CM, Tisch G, Chapman BA, Cook HB. Wilson IR, et al. Among authors: frampton cm. Gastrointest Endosc. 1991 Sep-Oct;37(5):527-30. doi: 10.1016/s0016-5107(91)70821-3. Gastrointest Endosc. 1991. PMID: 1936829

3

Gallbladder volume: comparison of diabetics and controls.

Chapman BA, Chapman TM, Frampton CM, Chisholm RJ, Allan RB, Wilson IR, Burt MJ. Chapman BA, et al. Among authors: frampton cm. Dig Dis Sci. 1998 Feb;43(2):344-8. doi: 10.1023/a:1018810523399. Dig Dis Sci. 1998. PMID: 9512128

4

The significance of haemochromatosis gene mutations in the general population: implications for screening.

Burt MJ, George PM, Upton JD, Collett JA, Frampton CM, Chapman TM, Walmsley TA, Chapman BA. Burt MJ, et al. Among authors: frampton cm. Gut. 1998 Dec;43(6):830-6. doi: 10.1136/gut.43.6.830. Gut. 1998. PMID: 9824612 Free PMC article.

5

Seroprevalence of Helicobacter pylori in the adult population of Christchurch: risk factors and relationship to dyspeptic symptoms and iron studies.

Collett JA, Burt MJ, Frampton CM, Yeo KH, Chapman TM, Buttimore RC, Cook HB, Chapman BA. Collett JA, et al. Among authors: frampton cm. N Z Med J. 1999 Aug 13;112(1093):292-5. N Z Med J. 1999. PMID: 10493426

6

Gallstone prevalence in Christchurch: risk factors and clinical significance.

Chapman BA, Frampton CM, Wilson IR, Chisholm RJ, Allan RB, Burt MJ. Chapman BA, et al. Among authors: frampton cm. N Z Med J. 2000 Feb 25;113(1104):46-8. N Z Med J. 2000. PMID: 10777222

7

Adult coeliac disease: prevalence and clinical significance.

Cook HB, Burt MJ, Collett JA, Whitehead MR, Frampton CM, Chapman BA. Cook HB, et al. Among authors: frampton cm. J Gastroenterol Hepatol. 2000 Sep;15(9):1032-6. doi: 10.1046/j.1440-1746.2000.02290.x. J Gastroenterol Hepatol. 2000. PMID: 11059933

8

The prevalence of viral hepatitis (HAV, HBV and HCV) in the Christchurch community.

Chapman BA, Burt MJ, Frampton CM, Collett JA, Yeo KH, Wilkinson ID, Cook HB, Barclay MJ, Ross AG, George PM. Chapman BA, et al. Among authors: frampton cm. N Z Med J. 2000 Sep 22;113(1118):394-6. N Z Med J. 2000. PMID: 11062814

9

Interferon-alpha2a/ribaviran versus interferon-alpha2a alone for the retreatment of hepatitis C patients who relapse after a standard course of interferon.

Chapman BA, Stace NH, Edgar CL, Bartlett SE, Frampton CM, Scahill SL, Jennings LC. Chapman BA, et al. Among authors: frampton cm. N Z Med J. 2001 Mar 23;114(1128):103-4. N Z Med J. 2001. PMID: 11346153 Clinical Trial.

10

Prevalence of Type 1 diabetes in New Zealanders aged 0-24 years.

Wu D, Kendall D, Lunt H, Willis J, Darlow B, Frampton C. Wu D, et al. N Z Med J. 2005 Jul 15;118(1218):U1557. N Z Med J. 2005. PMID: 16027748

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

568 results

Search Page